2 completed, 1 active not recruiting. 2 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Elagolix 200 MG: new trials by email Literature Review of Elagolix 200 MG trials Research Report on Elagolix 200 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp Elagolix 200 MG, Placebo or SOC IVF - Infertility, Endometriosis | Phase 3 | Active not recruiting | Yale University | 97 | 2024-03-16 | 2026-06-05 |
| Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis Elagolix 200 MG, Placebo or SOC IVF - Infertility, Endometriosis | Phase 3 | Completed | Yale University | 103 | 2022-03-15 | 2026-06-12 |
| Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work - Infertility, Endometriosis | Early Phase 1 | Completed | Colorado Center for Reproductive Medicine | 30 | 2020-09-01 | 2025-02-20 |
Endometriosis (3) · Infertility (3)
Yale University (2) · Colorado Center for Reproductive Medicine (1)
United States (3)
Emily Jungheim, MD (2) · Heping Zhang, PhD (2) · Hugh Taylor, MD (2) · Nanette Santoro, MD (2) · Steven Young, MD, PhD (2) · Abisola Tepede, PharmD (1) · David Weinberg, PhD (1) · Eric Surrey, MD (1) · Jim Segars, MD (1)
PMID 12372443, PMID 34363198, PMID 35715184
R01HD100336 (1)